Rhesus macaque CCR8 Full Length Protein (VLP)

AIDD‑Ready
Numéro de produit/spécification
Prix
Availability
Qté
CC8-R52P3-20ug
$620.00
In Stock - Delivery in 2-3 weeks
CC8-R52P3-100ug
$1,235.00
In Stock - Delivery in 2-3 weeks
CC8-R52P3-500ug (250ug X 2)
$4,305.00
In Stock - Delivery in 2-3 weeks
CC8-R52P3
Montant du produit :
$ 0
0
Ajouter au panier
Suggestion de nouveau produit Request Quote
Contact Us
Contact Us
Montant du produit:
$ 0
0
Ajouter au panier
  • Détails du produit
  • Affichage des données
  • Reviews & Citations
  • Important Statement
  • Resources
Application
  • Immunization
  • Cell based assay (FACS or functional assay)
  • Screening (ELISA)
Synonyms

CC chemokine receptor 8, CDw198, ChemR1, CKRL1, CKR-L1, CKRL1, CY6, GPRCL1, GPRCY6, GPR-CY6, TER-1

Source

Rhesus macaque CCR8 Full Length Protein (VLP) (CC8-R52P3) is expressed from human 293 cells (HEK293). It contains AA Asp 2 - Ser 319 (Accession # O97665 (C63Y, F122W, L169N, A237E, S290A, K307E)).

Predicted N-terminus: Asp

Molecular Characterization

*The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

Structure

Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

Synthesis Process

Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

Endotoxin

Less than 1.0 EU per μg by the LAL method / rFC method.

Formulation

The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

Shipping and Storage

This product is supplied and shipped on dry ice.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • The product MUST be stored at -70°C or lower upon receipt;
  • -70°C for 12 months under sterile conditions.

Introduction de fond

A chemokine receptor predominantly marking tumor-infiltrating regulatory T cells (Tregs) rather than peripheral Tregs. Targeting CCR8 enables selective depletion of immunosuppressive cells within the tumor microenvironment, thereby reinvigorating anti-tumor immunity without triggering systemic autoimmunity.